Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Cervical Occlusion During Intrauterine Insemination (IUI)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Women and Infants Hospital of Rhode Island.   Recruitment status was  Recruiting

First Received on July 31, 2009.   Last Updated on August 3, 2009   History of Changes
Sponsor: Women and Infants Hospital of Rhode Island
Information provided by: Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier: NCT00951171
  Purpose

Study Hypothesis: There is a difference in pregnancy rates between IUI in cycles performed with cervical occlusion by a balloon catheter designed for sonohysterograms as compared to those performed with a standard inseminator.

The investigators will compare pregnancy rates in patients undergoing routine IUI either with balloon occlusion or with standard insemination. The patients will receive the standard clinical care per the investigators' office guidelines, except they will be randomized to insemination with either of two catheters.


Condition Intervention Phase
Infertility
Procedure: Intrauterine Insemination
Procedure: IUI with the standard inseminator
Phase III

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Evaluation of the Effect of Cervical Occlusion During Infertility Treatment by Intrauterine Insemination

Resource links provided by NLM:


Further study details as provided by Women and Infants Hospital of Rhode Island:

Primary Outcome Measures:
  • clinical pregnancy [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • live birth [ Time Frame: 9 months ] [ Designated as safety issue: No ]
  • positive pregnancy test [ Time Frame: 14 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 160
Study Start Date: February 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cervical occulsion
Insemination Eliptosphere catheter filled with 1cc of air for 15 minutes. H/S Eliptosphere by Copper surgical (U.S. Patent No. 5,624,399)
Procedure: Intrauterine Insemination
The intervention arm will undergo temporary (15 minutes) cervical occlusion with the eliptosphere intracervical catheter. This catheter is typically used to perform saline infusion ultrasounds to image the uterine cavity in our practice.
Other Name: H/SH
Active Comparator: Standard IUI
Insemination with TOmcat catheter
Procedure: IUI with the standard inseminator
The control arm will undergo insemination with the standard inseminator (TOmcat catheter).

Detailed Description:

An open speculum will be used and patients will undergo insemination with their partners sperm (same quantity in both arms). If randomized to treatment arm a balloon catheter will be filled with 1cc of air prior to insemination. The speculum will be removed immediately and the catheter will be left in for 15 minutes and then removed. Pregnancy outcomes will be recorded in both groups.

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All patients undergoing IUI for unexplained infertility in our office: Center for Reproduction and Infertility (Providence, RI)

Exclusion Criteria:

  • "Abnormal" Semenalysis TMC < 5 million
  • Blocked Fallopian tubes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00951171

Contacts
Contact: Andrew Blazar, MD 401.274.1122 ext 8140 ablazar@wihri.org

Locations
United States, Rhode Island
Center for Reproduction and Infertility Recruiting
Providence, Rhode Island, United States, 02905
Contact: Lilian Czech, RN     401-274-1122 ext 7131     lczech@wihri.org    
Sub-Investigator: Peter C Klatsky, MD, MPH            
Principal Investigator: Andrew Blazar, MD            
Sponsors and Collaborators
Women and Infants Hospital of Rhode Island
Investigators
Principal Investigator: Andrew Blazar, MD Women & Infants Hospital
  More Information

No publications provided

Responsible Party: Dr. Andrew Blazar, Women & Infants' Hospital
ClinicalTrials.gov Identifier: NCT00951171     History of Changes
Other Study ID Numbers: CO_IUI
Study First Received: July 31, 2009
Last Updated: August 3, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on February 09, 2012